Preliminary observations on danazol therapy of systemic lupus erythematosus: effects on DNA antibodies, thrombocytopenia and complement
Danazol treatment of seven systemic lupus erythematosus patients showed decreases in DNA antibodies, increases in complement and platelets, and clinical improvement, suggesting potential benefits for mildly active SLE and thrombocytopenia.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
Cited by (19)
- Effects of Danazol on Clinical Improvement of Patients with Human T-cell Lymphotropic Virus Type I Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Placebo-Controlled Clinical Trial 2013
- Potential involvement of the immune system in the development of endometriosis 2003
- Effect of danazol on the immunocompetent cells in the eutopic endometrium in patients with endometriosis: a multicenter cooperative study 1996
- Leukocyte subpopulation changes in rats with autotransplanted endometrium and the effect of danazol 1995
- A controlled study of danazol for the treatment of karyotypically normal spontaneous premature ovarian failure 1994
- Immunosuppressive effect of danazol on lymphocyte-mediated cytotoxicity toward human endometrial stromal cells 1994
- Liver Damage Induced by Danazol 1994
- Local danazol injection for treatment of unruptured tubal pregnancy (preliminary experience) 1993
- Danazol suppresses both spontaneous and activated human lymphocyte-mediated cytotoxicity 1992
- The immune system in endometriosis 1991
- Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol 1991
- Danazol suppresses the production of interleukin-1 beta and tumor necrosis factor by human monocytes 1990
- Placebo-controlled comparison of hormonal and biochemical effects of danazol and high-dose medroxyprogesterone acetate 1990
- Immunologie Aspects of Endometriosis 1989
- Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus 1988
- Immunosuppressive effects of danazol in vitro 1987
- Efficacy of danazol in pure red cell aplasia 1986
- Danazol for lupus thrombocytopenia 1985
- Danazol therapy for autoimmune hemolytic anemia 1985
Source provenance
- openalex
- last seen: 2026-05-10T11:02:40.850500+00:00
- pubmed
- last seen: 2026-10-08T21:58:20.576574+00:00